Most Undervalued by Analyst Price Targets
Stocks with the highest upside potential to analyst consensus price targets — filtered for quality businesses with meaningful analyst coverage.
| Ticker | Company | Price | Upside | Target | P/E | Analysts |
|---|---|---|---|---|---|---|
| CTSO | Cytosorbents Corporation | $0.46 +0.17% | 1039.3% | $5.25 | — | 3 |
| CRBU | Caribou Biosciences | $2.10 +5.53% | 471.4% | $12.00 | — | 7 |
| NNOX | Nano-X Imaging | $1.84 -3.66% | 261.4% | $6.65 | — | 4 |
| CCCC | C4 Therapeutics | $3.56 +1.14% | 225% | $11.57 | — | 7 |
| OCUL | Ocular Therapeutix | $8.23 +0.12% | 215.9% | $26.00 | — | 11 |
| VKTX | Viking Therapeutics | $30.89 +0.68% | 198.9% | $92.33 | — | 18 |
| OPK | OPKO Health | $1.27 -0.78% | 196.1% | $3.76 | — | 5 |
| BLNK | Blink Charging | $0.82 -1.18% | 174.3% | $2.25 | — | 4 |
| HYQ.DE | Hypoport | $79.00 -3.25% | 169.3% | €212.75 | 18.7x | 4 |
| ARDX | Ardelyx | $6.11 -3.78% | 167.3% | $16.33 | — | 9 |
| CRVS | Corvus Pharmaceuticals | $12.61 -3.59% | 164.3% | $33.33 | — | 6 |
| FUTU | Futu Holdings | $89.76 -27.53% | 157.6% | $231.19 | 8.8x | 19 |
| EU | enCore Energy | $1.48 +0.68% | 157.5% | $3.81 | — | 4 |
| TELA | Tela Bio | $0.89 -3.51% | 152.8% | $2.25 | — | 5 |
| XNCR | Xencor | $11.31 +0.35% | 152% | $28.50 | — | 12 |
| EOLS | Evolent Health | $6.09 -5.58% | 140.8% | $14.67 | — | 6 |
| FATE | Fate Therapeutics | $2.25 +7.14% | 139.5% | $5.39 | — | 9 |
| MSTR | MicroStrategy | $159.89 -3.01% | 138.2% | $380.79 | — | 14 |
| RCAT | Red Cat Holdings | $9.41 +4.21% | 131.1% | $21.75 | — | 4 |
| NKTR | Nektar Therapeutics | $66.61 -2.87% | 130.1% | $153.25 | — | 8 |
| SPWH | Sportsmans Warehouse | $1.29 +0% | 126.1% | $2.92 | — | 3 |
| EVGO | EVgo | $1.88 +0% | 126.1% | $4.25 | — | 8 |
| RRGB | Red Robin Gourmet Burgers | $4.56 -2.15% | 122% | $10.12 | — | 4 |
| TTGT | TechTarget | $4.82 +5.01% | 121.3% | $10.67 | — | 3 |
| MNKD | MannKind Corporation | $3.38 +2.11% | 121% | $7.47 | — | 8 |
| RXRX | Recursion Pharmaceuticals | $3.01 -3.22% | 120.7% | $6.64 | — | 7 |
| TTK.DE | Takkt | $2.48 -8.49% | 119.1% | €5.43 | — | 3 |
| IOVA | Iovance Biotherapeutics | $4.11 +11.08% | 114.1% | $8.80 | — | 10 |
| EVEX | Eve Holding | $3.05 +3.74% | 111% | $6.44 | — | 7 |
| ATEC | Alphatec Holdings | $8.27 +0.49% | 109.6% | $17.33 | — | 12 |
| EDIT | Editas Medicine | $2.76 +3.37% | 109.3% | $5.78 | — | 9 |
| YEXT | Yext | $3.67 +2.23% | 104.4% | $7.50 | 52.4x | 4 |
| TNDM | Tandem Diabetes Care | $14.96 -5.04% | 104% | $30.52 | — | 21 |
| ADMA | ADMA Biologics | $8.24 -2.6% | 103.3% | $16.75 | 12.1x | 4 |
| PACB | Pacific Biosciences | $1.22 -2.4% | 101.5% | $2.46 | — | 6 |
| KTOS | Kratos Defense and Security | $56.18 +2.76% | 99.3% | $111.95 | 330.5x | 20 |
| QFIN | 360 Finance | $11.65 -5.74% | 99.1% | $23.20 | 1.8x | 12 |
| FYB.DE | Formycon | $20.05 +1.98% | 98.8% | €39.86 | — | 7 |
| SKIN | Beauty Health Company | $0.69 +4.21% | 95.1% | $1.34 | — | 6 |
| CMPS | COMPASS Pathways | $11.81 +1.9% | 90.5% | $22.50 | — | 14 |
| CLDX | Celldex Therapeutics | $30.73 +0.49% | 90.1% | $58.43 | — | 14 |
| DNLI | Denali Therapeutics | $18.64 -3.42% | 90.1% | $35.43 | — | 14 |
| PRAX | Praxis Precision Medicine | $343.56 -2% | 89.8% | $652.18 | — | 17 |
| INSM | Insmed | $106.24 -3% | 88.3% | $200.00 | — | 21 |
| ZLAB | Zymeworks | $18.61 -2.57% | 81.5% | $33.78 | — | 12 |
| TRUP | Trupanion | $21.98 +0.59% | 80.9% | $39.75 | 37.3x | 4 |
| DOMO | Domo | $3.63 +1.4% | 79.1% | $6.50 | — | 6 |
| SMMT | Summit Therapeutics | $16.62 -4.87% | 78.5% | $29.67 | — | 13 |
| BEAM | Beam Therapeutics | $28.64 +3.51% | 78.3% | $51.07 | — | 15 |
| AVAV | AeroVironment | $174.23 +6.83% | 77.9% | $309.88 | — | 17 |
| NA9.DE | Nagarro | $40.74 +0.84% | 77.3% | €72.25 | 10.8x | 4 |
| WKL.AS | Wolters Kluwer | $62.50 -0.83% | 76.9% | €110.54 | 11.1x | 14 |
| RMNI | Rimini Street | $3.63 +1.11% | 73.6% | $6.30 | 10.1x | 5 |
| BDT.DE | Bertrandt | $10.05 -6.51% | 73.1% | €17.40 | — | 5 |
| SMCP.PA | SMCP | $5.05 +0.5% | 72.5% | €8.72 | 24.1x | 5 |
| TMDX | TransMedics Group | $68.94 +0.12% | 71% | $117.89 | 15.8x | 9 |
| MGNI | Magnite | $13.20 +0.08% | 68.3% | $22.21 | 12.6x | 14 |
| CPNG | Coupang | $16.13 +2.54% | 68.1% | $27.12 | — | 17 |
| ACHR | Archer Aviation | $6.35 +3.76% | 67.1% | $10.61 | — | 9 |
| ARQT | Arcutis Biotherapeutics | $20.86 -0.71% | 66% | $34.62 | — | 8 |
| SKB.DE | Koenig and Bauer | $9.19 +3.61% | 65.9% | €15.25 | — | 4 |
| MOL.MI | Mutuionline | $31.40 +1.78% | 65.7% | €52.02 | 30.5x | 4 |
| ELF | elf Beauty | $52.93 -0.36% | 65.6% | $87.67 | 120.3x | 15 |
| ZEAL.CO | Zealand Pharma | $318.00 +0.98% | 63.2% | $519.07 | 3.6x | 15 |
| WIX | Wix | $53.19 -3.71% | 63.1% | $86.75 | — | 20 |
| ARLO | Arlo Technologies | $13.16 +3.37% | 62.6% | $21.40 | 47x | 5 |
| GSHD | Goosehead Insurance | $41.68 -1.91% | 61.6% | $67.33 | 36.6x | 12 |
| JACK | Jack in the Box | $11.55 +1.76% | 61.5% | $18.66 | — | 16 |
| SE | Sea Limited | $87.26 -1.91% | 61% | $140.50 | 34.4x | 28 |
| CLBT | Cellebrite DI | $13.18 +0.08% | 60.6% | $21.17 | 47.1x | 6 |
| RHM.DE | Rheinmetall | $1,227.20 +1.47% | 60.5% | €1,969.38 | 55.2x | 21 |
| GLJ.DE | Grenke | $12.62 -1.56% | 60.4% | €20.24 | 9.7x | 5 |
| STM.DE | Stabilus | $17.76 -1.22% | 59.2% | €28.27 | 29.1x | 7 |
| INVA | Innoviva | $22.46 +1.17% | 58.1% | $35.50 | 3.6x | 4 |
| AGI | Alamos Gold | $38.34 -2.32% | 57.8% | $60.50 | 15.3x | 4 |
| AOF.DE | Atoss Software | $79.80 +1.14% | 57.7% | €125.88 | 26.3x | 8 |
| NRDS | NerdWallet | $8.35 +1.83% | 57.7% | $13.17 | 9x | 6 |
| RYTM | Rhythm Pharmaceuticals | $87.84 -2.61% | 57.3% | $138.20 | — | 15 |
| SDGR | Schrodinger | $13.30 +0.53% | 57% | $20.88 | — | 8 |
| AVPT | AvePoint | $10.29 +0.49% | 56.7% | $16.12 | 51.5x | 13 |
| KELYA | Kelly Services | $10.66 -0.09% | 56.4% | $16.67 | — | 3 |
| ACVA | ACV Auctions | $5.93 +0.51% | 55.4% | $9.22 | — | 12 |
| IRTC | iRhythm Technologies | $116.56 -1.11% | 55.2% | $180.93 | — | 14 |
| TASK | TaskUs | $6.16 +0.65% | 54.2% | $9.50 | 5.5x | 6 |
| ALHC | Alignment Healthcare | $16.35 -0.12% | 53.9% | $25.15 | 163.5x | 13 |
| HDD.DE | Heidelberger Druckmaschinen | $1.35 +0% | 53.6% | €2.08 | 6.1x | 4 |
| NVAX | Novavax | $9.21 +2.56% | 53.2% | $14.11 | — | 9 |
| WEAV | Weave Communications | $5.71 +1.87% | 53.1% | $8.75 | — | 4 |
| SHAK | Shake Shack | $62.70 -0.21% | 53.1% | $95.96 | 64x | 25 |
| ITRI | Itron | $83.02 +1.43% | 52.6% | $126.70 | 13.3x | 10 |
| BILL | Bill.com Holdings | $36.11 -0.93% | 52.6% | $55.10 | — | 21 |
| VITR.ST | Vitrolife | $106.80 -1.48% | 52.4% | $162.75 | — | 4 |
| USPH | US Physical Therapy | $62.03 -0.58% | 51% | $93.67 | 124.1x | 6 |
| SK.PA | SEB | $48.96 +0.78% | 51% | €73.92 | 11x | 12 |
| OPRA | Opera | $17.43 -0.57% | 50.8% | $26.29 | 13.8x | 7 |
| SBS.DE | Stratec | $17.24 +1.17% | 50.8% | €26.00 | — | 5 |
| COUR | Coursera | $5.32 +1.43% | 50.5% | $8.00 | — | 10 |
| HLNE | Hamilton Lane | $90.32 +1.95% | 50.1% | $135.57 | 16.1x | 7 |
| ACAD | Acadia Pharmaceuticals | $21.10 -1.03% | 50% | $31.65 | 9.6x | 20 |
| ONTEX.BR | Ontex Group | $2.66 -3.27% | 49.8% | €3.98 | 13.3x | 6 |
| INRN.SW | Interroll Holding | $1,604.00 +3.48% | 49.6% | $2,400.00 | 23.9x | 7 |
| SF.ST | Stillfront Group | $5.16 -2.46% | 49.6% | $7.71 | — | 4 |
| DAVE | Dave Inc | $228.46 -5.16% | 49.4% | $341.38 | 14.7x | 8 |
| EUZ.DE | Eckert and Ziegler | $15.02 -0.99% | 49.4% | €22.43 | 19x | 3 |
| FSLY | Fastly | $16.32 -0.49% | 48.6% | $24.25 | — | 8 |
| WEW.DE | Westwing | $14.70 +3.89% | 48.5% | €21.83 | 133.6x | 3 |
| NEM.DE | Nemetschek | $63.35 -1.25% | 48.4% | €94.02 | 31.5x | 15 |
| XPER | Xperi | $7.73 +2.38% | 47.5% | $11.40 | — | 5 |
| KRUS | Kura Sushi USA | $54.28 -0.09% | 47.2% | $79.90 | — | 10 |
| CRM | Salesforce | $180.07 +2.13% | 47.2% | $265.01 | 23.1x | 53 |
| BABA | Alibaba | $129.99 -1.13% | 47.2% | $191.29 | 20.1x | 40 |
| SHOP | Shopify | $103.00 -1.77% | 47.1% | $151.56 | 101x | 45 |
| NCNO | nCino | $16.07 +1.52% | 47.1% | $23.64 | 321.4x | 14 |
| UPWK | Upwork | $8.80 +4.27% | 47.1% | $12.94 | 10.9x | 9 |
| BROS | Dutch Bros | $52.10 -2.54% | 47% | $76.58 | 81.4x | 24 |
| TOST | Toast | $23.15 +0.48% | 46.7% | $33.96 | 34.6x | 25 |
| FVRR | Fiverr | $11.10 +2.35% | 46.5% | $16.25 | 14.4x | 8 |
| NVCR | NovoCure | $17.96 +0.34% | 46.4% | $26.29 | — | 7 |
| AGIO | Agios Pharmaceuticals | $28.14 -2.26% | 46.1% | $41.12 | — | 8 |
| SAP | SAP | $175.80 -0.27% | 45.9% | $256.50 | 24.3x | 12 |
| QDT.PA | Quadient | $12.34 +3.01% | 45.5% | €17.96 | — | 7 |
| UBER | Uber | $71.83 -2.42% | 45.4% | $104.45 | 17.8x | 50 |
| HYPR | Hyperfine | $1.49 -0.67% | 45.4% | $2.17 | — | 3 |
| CERT | Certara | $5.24 +1.35% | 45.4% | $7.62 | — | 11 |
| RKT | Rocket Companies | $13.80 -0.5% | 45.3% | $20.05 | — | 14 |
| LSPD | Lightspeed Commerce | $8.55 +2.21% | 44.3% | $12.35 | — | 13 |
| TMCI | Treace Medical Concepts | $2.78 -2.11% | 43.9% | $4.00 | — | 3 |
| TMV.DE | TeamViewer | $5.71 +2.24% | 43.8% | €8.21 | 7.8x | 15 |
| ASAN | Asana | $6.62 +4.09% | 43.8% | $9.52 | — | 13 |
| TIP.MI | Tamburi Investment Partners | $8.64 +0.47% | 43.5% | €12.40 | 25.4x | 4 |
| SKYW | SkyWest Airlines | $84.82 +0.08% | 43.2% | $121.50 | 8.1x | 6 |
| BRZE | Braze | $24.35 +4.02% | 43.1% | $34.85 | — | 20 |
| G24.DE | Scout24 | $72.25 +2.92% | 42.7% | €103.12 | 20x | 16 |
| VTOL | Bristow Group | $42.73 -0.63% | 42% | $60.67 | 11.1x | 3 |
| ANAB | AnaptysBio | $59.71 -1.16% | 41.3% | $84.36 | — | 11 |
| MMSI | Merit Medical Systems | $64.17 +0.85% | 41.2% | $90.64 | 27.7x | 11 |
| LULU | Lululemon | $127.18 +0.33% | 41% | $179.36 | 9.6x | 25 |
| REY.MI | Reply SpA | $104.90 +0.96% | 40.8% | €147.67 | 14.8x | 12 |
| UPST | Upstart Holdings | $28.56 -1.01% | 40.8% | $40.20 | 69.7x | 15 |
| FOUR | Shift4 Payments | $43.23 -0.69% | 40.7% | $60.81 | 49.7x | 21 |
| GRND | Grindr | $12.96 +1.01% | 40.4% | $18.20 | 28.2x | 5 |
Analysis and Context
This screener currently shows 141 stocks meeting our value criteria — updated daily with live market data from 570+ tracked securities. The average P/E ratio of filtered stocks is 40.7x, compared to the historical S&P 500 median of 24.7x. The most represented sector is Healthcare with 53 companies. Value investing isn't simply about buying cheap stocks — it means identifying companies trading below intrinsic value before the market recognizes it. Low valuations can signal genuine mispricing, but may also reflect structural issues, cyclical weakness, or deserved discounts for deteriorating fundamentals. The average analyst price target upside for this list is 88.3%. Always combine these quantitative screens with qualitative analysis of competitive moats, management quality, and balance sheet strength before investing.
Ready to invest?
Compare the best brokers for US and European stocks — fees, platforms and account types side by side.
Compare brokers →